One of the most concerning emerging resistance traits among gram-negative bacteria is the ability of these organisms to produce carbapenem-hydrolysing β-lactamases, which confer resistance to almost all β-lactams.1 Carbapenem-resistant Enterobacteriaceae (CRE) are increasing in prevalence worldwide, causing growing concern, as they are often combined with non-β-lactam resistance to produce isolates that are multidrug resistant, have few treatment options available and are associated with high mortality rates.2
Although multiple resistance mechanisms have been identified, carbapenem resistance is often plasmid-encoded, allowing gene dissemination and a propensity to cause nosocomial outbreaks.3-6
Dandenong Hospital is a 440-bed tertiary referral hospital in Melbourne, Australia. The ICU has a 14-bed capacity, admitting both medical and surgical patients and averaging 1400 admissions yearly.
All environmental and patient screening swabs were cultured onto chromogenic agar (Brilliance CRE Agar, Oxoid). Suspect colonies were further characterised using the modified Hodge test and VITEK 2 (Biomérieux). All isolates with a meropenem minimum inhibitory concentration (MIC) ≥ 0.25 mg/L and a positive modified Hodge test result were forwarded for confirmation by polymerase chain reaction and molecular sequencing. Molecular typing using pulsed field gel electrophoresis (PFGE) was conducted on clinical and environmental isolates and interpreted as per the reference guidelines.7
Guidelines on ICU handwashing sink styles were reviewed to establish whether sinks met clinical design standards.8
Ten clinical isolates (Klebsiella pneumoniae [n = 5], Serratia marcescens [n = 4] and Enterobacter cloacae [n = 1]) and one screening isolate (Escherichia coli) containing the blaIMP-4 gene were detected over the 30-month period. There were four distinct CRE clusters, commencing with three cases of K. pneumoniae in November 2009, followed by two cases of S. marcescens 6 months later, three cases (two S. marcescens and one E. cloacae) after another 11 months, and three cases of K. pneumoniae in July 2012.
Clinical characteristics, patient demographics and ICU admission details of all 11 patients are summarised in Box 1. Patients acquired CRE after a median length of stay in ICU of 10 days (range, 3–134 days). No patient died due to clinical CRE infection. Patient 1 had a prolonged CRE bacteraemia that responded to removal of a central venous catheter, the presumed source of infection.
Sink inspection revealed aged and deteriorating porcelain, even though sinks were only installed in 2005. Sink design did not comply with Australasian clinical design standards,8 with a small, shallow sink and a tap that directed water over the drain (Box 2). The design of the ICU sinks led to poor use for hand hygiene (although measured hand hygiene compliance using alcoholic hand rub was around 70% within the unit) and the potential for organisms residing down the drain to be splashed back onto staff hands or contaminate patient areas. It was also revealed that the handwashing sinks had been used incorrectly, with staff disposing clinical waste and residual antibiotics directly into drains. Further enquiry also revealed that a single brush had been used to clean down the drains of all sinks in the ICU without disinfection between sinks.
We report an outbreak of CRE in an ICU with identical organisms isolated from patients and an environmental source (sinks).
Dissemination of carbapenemase-resistant bacteria has been reported previously in an ICU in Australia, with 62 patients infected or colonised with gram-negative bacteria from multiple genera containing the blaIMP-4 gene.9 The gene is carried on a highly mobile plasmid making it efficient for nosocomial transmission. The gene can reside in multiple genera of hardy environmental organisms that can establish a reservoir within biofilm.
Others have reported outbreaks of multiresistant bacteria such as extended-spectrum β-lactamase-producing K. pneumoniae linked to imperfect sink design requiring sink cleaning, replacement and/or improved sink practices to successfully control the outbreaks.10
1 Demographics and intensive care unit (ICU) admissions for patients with carbapenem-resistant Enterobacteriaceae isolates
Received 30 November 2012, accepted 3 February 2013
Abstract
Objectives: Clinical utility of carbapenem antibiotics is under threat because of the emergence of acquired metallo-β-lactamase (MBL) genes. We describe an outbreak in an intensive care unit (ICU) possibly associated with contaminated sinks.
Design, setting and participants: Four clusters of gram-negative bacteria harbouring the MBL gene blaIMP-4 were detected in the ICU at Dandenong Hospital between November 2009 and July 2012. Epidemiological investigations were undertaken in order to identify a common point source. During September 2012, screening using rectal swabs for all ICU patients, and environmental swabs targeting all ICU handwashing sinks and taps were collected. Samples were cultured onto selective carbapenem-resistant Enterobacteriaceae (CRE) agar. Suspected CRE isolates were further characterised using the modified Hodge test and VITEK 2 and confirmed by polymerase chain reaction and sequencing of MBL genes. Clinical and environmental CRE isolates were typed by pulsed-field gel electrophoresis.
Results: Ten clinical isolates and one screening isolate of CRE (consisting of Klebsiella pneumoniae [5], Serratia marcescens [4], Enterobacter cloacae [1] and Escherichia coli [1]) were detected with the blaIMP-4 gene over the 30-month period. S. marcescens was isolated persistently from the grating and drain of eight central sinks. Molecular typing confirmed that clinical and environmental isolates were related. Tap water cultures were negative. Several attempts to clean and decontaminate the sinks using detergents and steam cleaning proved unsuccessful.
Conclusion: This report highlights the importance of identification of potential environmental reservoirs, such as sinks, for control of outbreaks of environmentally hardy multiresistant organisms.